Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Supply, Demand and Key Producers, 2024-2030
Page: 121
Published Date: 14 Dec 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.
Table of Contents
1 Supply Summary
1.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
1.2 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.3 China Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.4 Europe Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.5 Japan Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.6 South Korea Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.7 ASEAN Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.3.8 India Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.2 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region
2.2.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2019-2024)
2.2.2 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Forecast by Region (2025-2030)
2.3 United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.4 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.5 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.6 Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.7 South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.8 ASEAN Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
2.9 India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030)
3.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service in 2023
3.2.3 Global Concentration Ratios (CR8) for Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service in 2023
3.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Company Evaluation Quadrant
3.4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Region Footprint
3.4.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Type Footprint
3.4.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4.1 United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies and Market Share, 2019-2024
4.3.1 United States Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, (2019-2024)
4.4 China Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue and Market Share, 2019-2024
4.4.1 China Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, (2019-2024)
4.5 Rest of World Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2024)
5.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Cell-derived Products
5.3 Market Segment by Type
5.3.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
5.3.2 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
5.3.3 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Type (2025-2030)
6.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Large Pharmaceutical Company
6.2.2 Small and Medium-sized Pharmaceutical Company
6.3 Market Segment by Application
6.3.1 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
6.3.2 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
6.3.3 World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Application (2019-2030)
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.1.4 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 uBriGene Biosciences International
7.2.1 uBriGene Biosciences International Details
7.2.2 uBriGene Biosciences International Major Business
7.2.3 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.2.4 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 uBriGene Biosciences International Recent Developments/Updates
7.2.6 uBriGene Biosciences International Competitive Strengths & Weaknesses
7.3 Thermo Fisher
7.3.1 Thermo Fisher Details
7.3.2 Thermo Fisher Major Business
7.3.3 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.3.4 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Thermo Fisher Recent Developments/Updates
7.3.6 Thermo Fisher Competitive Strengths & Weaknesses
7.4 Creative Biolabs
7.4.1 Creative Biolabs Details
7.4.2 Creative Biolabs Major Business
7.4.3 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.4.4 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Creative Biolabs Recent Developments/Updates
7.4.6 Creative Biolabs Competitive Strengths & Weaknesses
7.5 REPROCELL
7.5.1 REPROCELL Details
7.5.2 REPROCELL Major Business
7.5.3 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.5.4 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 REPROCELL Recent Developments/Updates
7.5.6 REPROCELL Competitive Strengths & Weaknesses
7.6 ATCC
7.6.1 ATCC Details
7.6.2 ATCC Major Business
7.6.3 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.6.4 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 ATCC Recent Developments/Updates
7.6.6 ATCC Competitive Strengths & Weaknesses
7.7 Beijing CytoNiche Biotech
7.7.1 Beijing CytoNiche Biotech Details
7.7.2 Beijing CytoNiche Biotech Major Business
7.7.3 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.7.4 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Beijing CytoNiche Biotech Recent Developments/Updates
7.7.6 Beijing CytoNiche Biotech Competitive Strengths & Weaknesses
7.8 OmniaBio
7.8.1 OmniaBio Details
7.8.2 OmniaBio Major Business
7.8.3 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.8.4 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 OmniaBio Recent Developments/Updates
7.8.6 OmniaBio Competitive Strengths & Weaknesses
7.9 Histocell
7.9.1 Histocell Details
7.9.2 Histocell Major Business
7.9.3 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.9.4 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Histocell Recent Developments/Updates
7.9.6 Histocell Competitive Strengths & Weaknesses
7.10 FUJIFILM Diosynth Biotechnologies
7.10.1 FUJIFILM Diosynth Biotechnologies Details
7.10.2 FUJIFILM Diosynth Biotechnologies Major Business
7.10.3 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.10.4 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.10.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.11 Taiwan Bio Therapeutics
7.11.1 Taiwan Bio Therapeutics Details
7.11.2 Taiwan Bio Therapeutics Major Business
7.11.3 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.11.4 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Taiwan Bio Therapeutics Recent Developments/Updates
7.11.6 Taiwan Bio Therapeutics Competitive Strengths & Weaknesses
7.12 Encell Co., Ltd.
7.12.1 Encell Co., Ltd. Details
7.12.2 Encell Co., Ltd. Major Business
7.12.3 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.12.4 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Encell Co., Ltd. Recent Developments/Updates
7.12.6 Encell Co., Ltd. Competitive Strengths & Weaknesses
7.13 Mycenax
7.13.1 Mycenax Details
7.13.2 Mycenax Major Business
7.13.3 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
7.13.4 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Mycenax Recent Developments/Updates
7.13.6 Mycenax Competitive Strengths & Weaknesses
8.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Chain
8.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Upstream Analysis
8.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Midstream Analysis
8.4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players in 2023
Table 12. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players
Table 15. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Type Footprint
Table 16. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Application Footprint
Table 17. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share (2019-2024)
Table 23. China Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share (2019-2024)
Table 26. Rest of World Based Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share (2019-2024)
Table 29. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (USD Million)
Table 32. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (USD Million)
Table 34. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (USD Million)
Table 35. Lonza Basic Information, Manufacturing Base and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 38. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. uBriGene Biosciences International Basic Information, Manufacturing Base and Competitors
Table 42. uBriGene Biosciences International Major Business
Table 43. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 44. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. uBriGene Biosciences International Recent Developments/Updates
Table 46. uBriGene Biosciences International Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 48. Thermo Fisher Major Business
Table 49. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 50. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Thermo Fisher Recent Developments/Updates
Table 52. Thermo Fisher Competitive Strengths & Weaknesses
Table 53. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 54. Creative Biolabs Major Business
Table 55. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 56. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Creative Biolabs Recent Developments/Updates
Table 58. Creative Biolabs Competitive Strengths & Weaknesses
Table 59. REPROCELL Basic Information, Manufacturing Base and Competitors
Table 60. REPROCELL Major Business
Table 61. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 62. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. REPROCELL Recent Developments/Updates
Table 64. REPROCELL Competitive Strengths & Weaknesses
Table 65. ATCC Basic Information, Manufacturing Base and Competitors
Table 66. ATCC Major Business
Table 67. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 68. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. ATCC Recent Developments/Updates
Table 70. ATCC Competitive Strengths & Weaknesses
Table 71. Beijing CytoNiche Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Beijing CytoNiche Biotech Major Business
Table 73. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 74. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Beijing CytoNiche Biotech Recent Developments/Updates
Table 76. Beijing CytoNiche Biotech Competitive Strengths & Weaknesses
Table 77. OmniaBio Basic Information, Manufacturing Base and Competitors
Table 78. OmniaBio Major Business
Table 79. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 80. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. OmniaBio Recent Developments/Updates
Table 82. OmniaBio Competitive Strengths & Weaknesses
Table 83. Histocell Basic Information, Manufacturing Base and Competitors
Table 84. Histocell Major Business
Table 85. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 86. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Histocell Recent Developments/Updates
Table 88. Histocell Competitive Strengths & Weaknesses
Table 89. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 90. FUJIFILM Diosynth Biotechnologies Major Business
Table 91. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 92. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 94. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 95. Taiwan Bio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. Taiwan Bio Therapeutics Major Business
Table 97. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 98. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Taiwan Bio Therapeutics Recent Developments/Updates
Table 100. Taiwan Bio Therapeutics Competitive Strengths & Weaknesses
Table 101. Encell Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 102. Encell Co., Ltd. Major Business
Table 103. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 104. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Encell Co., Ltd. Recent Developments/Updates
Table 106. Encell Co., Ltd. Competitive Strengths & Weaknesses
Table 107. Mycenax Basic Information, Manufacturing Base and Competitors
Table 108. Mycenax Major Business
Table 109. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Services
Table 110. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Mycenax Recent Developments/Updates
Table 112. Mycenax Competitive Strengths & Weaknesses
Table 113. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Upstream (Raw Materials)
Table 114. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Typical Customers
List of Figures
Figure 1. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Picture
Figure 2. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Total Revenue (2019-2030) & (USD Million)
Figure 4. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (2019-2030) & (USD Million)
Figure 13. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 16. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 18. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 23. India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Markets in 2023
Figure 27. United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Type in 2023
Figure 31. Cell Therapy
Figure 32. Cell-derived Products
Figure 33. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Type (2019-2030)
Figure 34. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Application in 2023
Figure 36. Large Pharmaceutical Company
Figure 37. Small and Medium-sized Pharmaceutical Company
Figure 38. World Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Market Share by Application (2019-2030)
Figure 39. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Lonza uBriGene Biosciences International Thermo Fisher Creative Biolabs REPROCELL ATCC Beijing CytoNiche Biotech OmniaBio Histocell FUJIFILM Diosynth Biotechnologies Taiwan Bio Therapeutics Encell Co., Ltd. Mycenax
14 Dec 2024
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
